Delivery Order SPE2DB22D1017-SPE2DB24FG0JV

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565152518 - Dorzolamide HCL 2% Eye Drops 10 ML. The contract is a Delivery Order with a Firm Fixed Price of $7,448.11 and a completion date of July 16, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, one of the largest...
This federal contract award, valued at $1,772.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4564260040 - Dorzolamide-Timolol Eye Drops 10ML, a pharmaceutical product, with a performance period through April 15, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,888.01 firm fixed-price delivery order is for the supply of Dorzolamide-Timolol eye drops, which are used to treat glaucoma and elevated eye pressure. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. It is not designated as a set-aside contract....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,442.75, is for the delivery of Dorzolamide-Timolol eye drops, a pharmaceutical product used for the treatment of eye conditions. The contract is a delivery order, with a firm-fixed price pricing type and an ultimate completion date of January 29, 2025. Amerisourcebergen holds a significant...
This federal contract award, valued at $3,484.43, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of 4566572752 ! DORZOLAMIDE-TIMOLOL EYE DROPS 10ML, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through December 2, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of dorzolamide-timolol eye drops, a prescription medication, valued at $5,129.75. This is a firm fixed-price delivery order contract with a completion date of January 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Dorzolamide-Timolol eye drops. The contract has a ceiling value of $1,046.95 and a completion date of November 4, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,663.23 firm fixed-price contract is for the delivery of 4567074296 - DORZOLAMIDE-TIMOLOL EYE DROPS 10ML. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,642.16 firm fixed price delivery order is for the supply of 10 milliliter bottles of Dorzolamide-Timolol Eye Drops, a pharmaceutical product. The contract has a completion date of January 8, 2024 and was awarded on January 5, 2024. The place of performance is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,276.47 firm-fixed-price contract is for the supply of 4564571331 - Dorzolamide-Timolol Eye Drops 10ML. The award does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG0JV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,861.67 firm-fixed-price delivery order is for the supply of 4565030961 - Dorzolamide-Timolol eye drops, 10 mL. The contract has an ultimate completion date of July 1, 2024 and was awarded on June 28, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any specific business type.

Generated 9/27/24, 9:04 AM